SEMAGLUTIDE & TIRZEPATIDE

Semaglutide and Tirzepatide are a modified molecule our bodies make, GLP1. It’s a protein made in the intestine and results in a decrease in blood sugars and appetite. Technically, Semaglutide and Tirzepatide function by mimicking glucagon-like peptide-1 (GLP-1), a hormone the body naturally produces. GLP-1 is normally secreted in the gut when we eat fats and carbohydrates. When this hormone is released, it targets various receptors in the body to help stimulate insulin release, while also suppressing glucagon, slowing gastric emptying, and increasing feelings of fullness. 

In basic terms, the actions this hormone takes when released, as described above, all add up to signal to the brain that we feel full and content after eating. With the steady supply of this hormone that Semaglutide and Tirzepatide provide, patients receive signals to the brain telling them they are full after eating much smaller portions.

The half-life of Semaglutide and Tirzepatide is 6.6 days. This means the appetite suppression is able to last for a week in our bodies rather than minutes. It is administered once per week via subcutaneous injection. Patients can expect on average a weight loss reduction of 15-20%. 

Disclaimer - BMI under 27 will not be treated. Labs required before acceptance into the program (CBC, CMP, Lipid Panel, Thyroid Panel, and A1C).

16 week Program - $2,350 

0% Financing options are available